Why the study?
Does the addition of hydralazine to propranolol increase plasma volume and extracellular fluid volume in patients with uncontrolled hypertension?
Does the addition of hydralazine to propranolol increase plasma volume and extracellular fluid volume in patients with uncontrolled hypertension?
The addition of hydralazine to propranolol in hypertensive patients causes significant fluid retention, suggesting the need for concomitant diuretic therapy.
Answers are grounded in this paper and cite their sources.
Hydralazine added to propranolol was associated with volume expansion; supports diuretic co-therapy consideration but leaves open need for randomized trials.
In 16 patients with hypertension, BP could not be controlled satisfactorily by treatment with propranolol alone (mean dosage 325 mg/day). Plasma volume (PV) (T-1824) and extracellular fluid volume (ECV) (82Br-distribution space) were determined in these patients before and after the addition of hydralazine for three months (mean dosage 135 mg/day). After the addition of hydralazine, PV and ECV increased significantly, by 9% and 3%, respectively. Systolic and diastolic BPs decreased, by 15% and 13%. The mechanisms inducing fluid retention during treatment with hydralazine and the clinical significance of the problem are discussed. It is concluded that the addition of a diuretic to propranolol-hydralazine treatment is often well indicated.
No takes yet. Share an insight, caveat, or question.
Ibsen et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: